No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
FMS240816P17500
- 0.15
- -0.05-25.00%
15min DelayTrading Jul 22 12:45 ET
0.15High0.15Low
0.15Open0.20Pre Close6 Volume67 Open Interest17.50Strike Price90.00Turnover41.21%IV11.34%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.1331Delta0.1009Gamma130.47Leverage Ratio-0.0086Theta-0.0017Rho-17.36Eff Leverage0.0111Vega
Intraday
- 5D
- Daily
News
Fresenius Medical Care Says IT Outage Didn't Affect Its Patient Care -- Market Talk
1403 GMT - Fresenius Medical Care says that a global IT outage didn't affect its patient care. The German dialysis provider says its employees were affected by IT issues, which are mostly resolved
Deutsche Numis Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Berenberg Bank Remains a Buy on Fresenius Medical Care AG & Co. KGaA (0H9X)
Express News | DaVita and Fresenius Shares Are Trading Lower Following a Report Suggesting the FTC Is Investigating the Companies
Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk
0814 GMT - U.S. Federal Trade Commission's probe into Fresenius Medical Care and DaVita's unfair business practices to hinder smaller competitors could open doors for greater competition and a shift
Express News | US Federal Trade Commission Is Investigating Dialysis Providers DaVita and Fresenius Medical Care- Politico
Comments
Michael Sen and Helen Giza show confidence in Cordola's leadership for Care Delivery due to his extensive experience. They believe he'll be crucial for Fresenius Medical Care's ongoing transformation focusing on patient care.
Press Release: Fresenius Medical Care Appoints Craig Cordola as New Management Board Member for Care Delivery
ColumnsNovo Nordisk Sets New Record High: Analyzing the Market Effects of Popular GLP-1 Weight Loss Drugs
The increasing demand for GLP-1 weight-loss medications indicates that in the next ten years, a significant number of Americans may lose hundreds of millions of pounds collectively. This shift in weight could cause a redistribution of trillions of dollars.
Last week, $Novo-Nordisk A/S(NVO.US$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
Last week, $Novo-Nordisk A/S(NVO.US$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
16
Weight loss drugs lead the stock market
As GLP-1 diet drug companies have grown in influence, they have grown to be the new leaders of the stock market.
$Novo-Nordisk A/S(NVO.US$ , with Wegovy and Ozempic in hand, is now Europe's largest company with a market capitalization of $433 billion, and the Danish drug giant's rapid growth has even had a direct impact on the Danish krone exchange rate and interest rates.![]()
Meanwhile, $Eli Lilly and Co(LLY.US$ , whic...
As GLP-1 diet drug companies have grown in influence, they have grown to be the new leaders of the stock market.
$Novo-Nordisk A/S(NVO.US$ , with Wegovy and Ozempic in hand, is now Europe's largest company with a market capitalization of $433 billion, and the Danish drug giant's rapid growth has even had a direct impact on the Danish krone exchange rate and interest rates.
Meanwhile, $Eli Lilly and Co(LLY.US$ , whic...
5
Drugs used for weight loss like Ozempic pose a real risk to companies ranging from fast food restaurants to cigarette makers. Expect management teams of public companies to talk about them in their earnings calls.
Ozempic and Wegovy, two weight-loss medications, function by simulating the hormone that signals to people's brains when they are not hungry. Recent anecdotal data indicates that the medicine might reduce users' craving...
Ozempic and Wegovy, two weight-loss medications, function by simulating the hormone that signals to people's brains when they are not hungry. Recent anecdotal data indicates that the medicine might reduce users' craving...
11
1
MACRO
Waller Says Fed 'Finally' Getting Good Inflation Data
"In the last few months, we are finally getting very good inflation data that we wanted." Federal Reserve Governor Christopher Waller says at the annual E2 Summit in Park City, Utah. "If this continues, we're back to our target."
U.S. Stocks Trade Mixed After Fed Minutes, Wholesale Inflation Data
U.S. stocks were trading mixed Wednesday afternoon after the Federal ...
Waller Says Fed 'Finally' Getting Good Inflation Data
"In the last few months, we are finally getting very good inflation data that we wanted." Federal Reserve Governor Christopher Waller says at the annual E2 Summit in Park City, Utah. "If this continues, we're back to our target."
U.S. Stocks Trade Mixed After Fed Minutes, Wholesale Inflation Data
U.S. stocks were trading mixed Wednesday afternoon after the Federal ...
25
5
Read more